There’s a push underway to bring AI doctors into American medicine, and it’s got Trump’s backing. Not AI-assisted diagnostics or decision support tools — actual AI systems making medical calls, triaging patients, prescribing treatments. The kind of thing that sounds like science fiction until you realize venture capital has already written the checks and lobbyists have already drafted the legislation.
The promise, as always, is efficiency. Faster diagnoses. Lower costs. Expanded access to underserved communities. All the greatest hits from the tech disruption playbook, now applied to the thing keeping you alive.
The reality — well, that’s where it gets interesting.
The Pitch: Silicon Valley Meets the Stethoscope
The companies pushing AI doctors America-wide frame this as inevitable progress. Medicine is slow, expensive, gatekept by credentialing boards and insurance bureaucracies. Why not let algorithms handle the routine stuff? Sore throats, rashes, prescription refills. Free up human doctors for the complex cases.
Sounds reasonable until you ask who defines “routine.” Or what happens when the algorithm encounters an edge case it wasn’t trained on. Or who gets sued when the chatbot misses the early signs of sepsis because the patient’s symptoms didn’t match the statistical norm.
Nobody’s worked that part out yet. But the pilot programs are already running.
What Could Possibly Go Wrong
Let’s start with the obvious: medical algorithms are only as good as their training data. And medical training data is notoriously biased — skewed toward white, male patients because that’s who dominated clinical trials for decades. An AI trained on that data doesn’t just replicate the bias; it scales it. Exponentially.
Then there’s the liability question. When a human doctor screws up, there are malpractice insurance, licensing boards, and professional consequences. When an AI screws up, the company behind it points to the terms of service you didn’t read and the legal disclaimers buried in the user agreement. Good luck suing an algorithm.
And the profit motive — always the profit motive. These aren’t public health initiatives. They’re venture-backed startups looking for an exit. The incentive structure isn’t “provide the best care.” It’s “scale fast, monetize data, get acquired before the lawsuits pile up.”
The Regulatory Vacuum
The FDA regulates medical devices. It doesn’t really regulate software that makes medical decisions — not in any coherent way. There are guidelines, sure. Recommendations. But the regulatory framework was built for scalpels and pacemakers, not neural networks that update themselves overnight.
So we’re in this bizarre limbo where AI systems can practice medicine without the same scrutiny a human doctor would face. No residency. No board exams. No peer review. Just a software update and a press release about “cutting-edge innovation.”
The Trump administration’s approach seems to be “let the market figure it out.” Deregulate, incentivize, see what happens. It’s the same philosophy that led to the 2008 financial crisis, now applied to your gallbladder.
The Underserved Communities Argument
Proponents love to talk about rural America. Small towns that can’t attract doctors. Communities where the nearest hospital is an hour away. AI could fill that gap, they say. Bring medical expertise to places that don’t have it.
Except — and this is the part that never makes the pitch deck — those communities also tend to have spotty internet, older populations less comfortable with technology, and higher rates of complex chronic conditions that don’t fit neatly into algorithmic categories.
So what you’re really proposing is a two-tiered system: rich people get human doctors, poor people get chatbots. That’s not innovation. That’s just rebranding inequality with a Silicon Valley aesthetic.
The Efficiency Trap
Healthcare isn’t slow because doctors are inefficient. It’s slow because the body is complicated and medicine is as much art as science. A good diagnosis requires context, intuition, the ability to read between the lines when a patient says they’re “fine” but their body language screams otherwise.
Algorithms don’t do nuance. They do pattern matching. And when the pattern doesn’t fit, they either force it into the nearest category or kick it back to a human — who now has to waste time undoing the algorithmic triage before they can actually help.
This isn’t efficiency. It’s automation theater. The appearance of progress without the substance.
What Happens Next
The pilot programs will expand. The lobbying will intensify. Somewhere, a senator who doesn’t understand how any of this works will give a speech about “American innovation” and “healthcare of the future.”
Insurance companies will love it because algorithms are cheaper than doctors. Hospital administrators will love it because it looks good in quarterly earnings reports. Patients will tolerate it because they won’t have a choice — it’ll be the AI or nothing, take it or leave it.
And when the first major scandal hits — and it will hit, because this is medicine and the stakes are life and death — there will be congressional hearings, think pieces, promises of reform. Then the news cycle will move on, and the AI doctors will still be here, making decisions, writing prescriptions, practicing medicine without a license.
The future of American healthcare, brought to you by venture capital and regulatory capture.
Source: Washington Post